首页> 美国卫生研究院文献>Oncogenesis >Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
【2h】

Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers

机译:实体癌的内质网应激信号和化疗耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The unfolded protein response (UPR) is an adaptive cellular program used by eukaryotic cells to cope with protein misfolding stress. During tumor development, cancer cells are facing intrinsic (oncogene activation) and extrinsic (limiting nutrient or oxygen supply) challenges, with which they must cope to survive. Moreover, chemotherapy represents an additional extrinsic challenge that cancer cells are facing and to which they adapt in the case of resistance. As of today, resistance to chemotherapy and targeted therapies is one of the important issues that oncologists have to deal with for treating cancer patients. In this review, we first describe the key molecular mechanisms controlling the UPR and their implication in solid cancers. Then, we review the literature that connects cancer chemotherapy resistance mechanisms and activation of the UPR. Finally, we discuss the possible applications of targeting the UPR to bypass drug resistance.
机译:未折叠的蛋白质反应(UPR)是真核细胞用于应对蛋白质错误折叠压力的适应性细胞程序。在肿瘤发展过程中,癌细胞面临内在(致癌基因激活)和外在(限制营养或氧气供应)的挑战,它们必须应付生存。此外,化学疗法代表了癌细胞所面临的另一种外部挑战,在耐药性的情况下,癌细胞也要适应这种挑战。到目前为止,对化学疗法和靶向疗法的耐药性是肿瘤学家治疗癌症患者必须解决的重要问题之一。在这篇综述中,我们首先描述了控制UPR的关键分子机制及其在实体癌中的意义。然后,我们回顾了将癌症化疗耐药机制与UPR激活联系起来的文献。最后,我们讨论了针对UPR绕过耐药性的可能应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号